Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mirxes Holding Company Limited ( (HK:2629) ) has issued an update.
Mirxes Holding Company Limited has entered into a memorandum of understanding with PT Diastika Biotekindo to collaborate on the registration and commercialization of molecular diagnostic tests for cancer detection in Indonesia. This collaboration aims to address Indonesia’s significant cancer burden by improving early detection rates, leveraging PT Diastika Biotekindo’s extensive hospital network and Mirxes’ innovative diagnostic technologies.
More about Mirxes Holding Company Limited
Mirxes Holding Company Limited, incorporated in the Cayman Islands, is involved in the development and commercialization of molecular diagnostic tests, focusing on early detection and diagnosis of high incidence and high mortality cancers.
Average Trading Volume: 1,131,713
Current Market Cap: HK$9.81B
For detailed information about 2629 stock, go to TipRanks’ Stock Analysis page.